Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell

Yoshihiro Kameoka1, Hiroyuki Tagawa, Shinobu Tsuzuki

  • 1Division of Molecular Medicine, Aichi Cancer Center Research Institute, Aichi, Japan.

Oncogene
|October 14, 2004
PubMed

Insights

Genomic deletions in the 3p14.2 region, specifically within the fragile histidine triad (FHIT) gene, are linked to aberrant FHIT gene transcription in diffuse large B-cell lymphoma (DLBCL). This study highlights FHIT gene loss as a factor in DLBCL development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Deletions on the 3p chromosome arm are observed in various solid tumors.
  • The role of 3p deletions in diffuse large B-cell lymphoma (DLBCL) has not been previously studied.

Purpose of the Study:

  • To investigate genomic losses at 3p14.2 in DLBCL.
  • To examine the association between these deletions and the fragile histidine triad (FHIT) gene.
  • To determine the impact on FHIT gene transcription.

Main Methods:

  • Genome-wide array-comparative genomic hybridization (CGH) was initially used to identify 3p14.2 deletions in DLBCL.
  • A targeted contig BAC array was employed for detailed analysis of 3p14.2 genomic losses.
  • Transcriptional analysis was performed to assess FHIT gene expression.

Main Results:

  • Approximately 30% of DLBCL cases showed deletions at 3p14.2.
  • All identified deletions were located within the FHIT gene, with a common region encompassing introns 4-5 and exon 5.
  • Aberrant FHIT gene transcription was observed in 31% of DLBCL samples, correlating with genomic deletions.

Conclusions:

  • Genomic losses at 3q14.2 directly cause exon losses in the FHIT gene.
  • FHIT gene deletion is a contributing factor to the generation of aberrant FHIT transcripts in DLBCL.

Related Concept Videos